CordSavings: The Bank of Life for Your Child's Future CordSavings has developed a unique and unprecedented biobank in Switzerland, combining rigorous expertise with the natural desire of parents to preserve their baby's umbilical cord blood stem cells at birth. This innovative approach ensures secure and reliable storage, meeting the highest standards while offering families a valuable opportunity for their child's future. Autologous Storage: A Legacy for Your Child's Future We offer a comprehensive service for the collection, processing, and cryopreservation of your baby's stem cells, exclusively for personal or family use. These stem cells, already recognized for their crucial role in transplants, open promising prospects for the regenerative medicine of tomorrow. Simplicity and Safety The collection is performed at birth, directly from the umbilical cord blood. This process is entirely safe, painless, and risk-free for both the mother and the baby. Unmatched Quality Our services adhere to the highest standards of quality and safety, ensuring optimal preservation of your child's stem cells. Flexible Solutions To meet the needs of every family, we offer a range of payment plans to suit all budgets. Secure your child's future today! Contact us to receive comprehensive documentation and personalized advice. We are here to support you every step of the way. With CordSavings, give your child the chance to benefit from the therapies of tomorrow.

I have studied pharmacy with a partial focus on medicine and pursued advanced training over the years in the fields of genetics and cancer immunology. I am here to assist you in finding the best cancer therapy worldwide and guide you from your initial inquiry to the completion of the treatment. With 25 years of experience in Big Pharma and as the director of specialized clinics in Dubai, I have had the privilege of working alongside dedicated physicians and scientists who have successfully developed innovative cancer therapies. Today, I take pride in having them as part of our Iaso Cancer Initiative. Bruno Rosset